• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Laura A. Guay, Philippa Musoke, Thomas Fleming, Danstan S Bagenda, Jay Brooks Jackson
  • Medicine
  • The Lancet
  • 1999 (First Published: 4 September 1999)
  • BACKGROUND The AIDS Clinical Trials Group protocol 076 zidovudine prophylaxis regimen for HIV-1-infected pregnant women and their babies has been associated with a significant decrease in verticalContinue Reading
  • Elliot Marseille, James G Kahn, Francis A Mmiro, Laura A. Guay, Jay Brooks Jackson
  • Medicine
  • The Lancet
  • 1999 (First Published: 4 September 1999)
  • BACKGROUND Identification of economical interventions to decrease HIV-1 transmission to children is an urgent public-health priority in sub-Saharan Africa. We assessed the cost effectiveness of theContinue Reading
  • Wei Huang, Susan H Eshleman, +12 authors Christos J. Petropoulos
  • Biology, Medicine
  • Journal of virology
  • 2007 (First Published: 1 August 2007)
  • In human immunodeficiency virus type 1 (HIV-1) subtype B, CXCR4 coreceptor use ranges from approximately 20% in early infection to approximately 50% in advanced disease. Coreceptor use by non-subtypeContinue Reading
  • Newton I. Kumwenda, Paolo G. Miotti, +5 authors Richard David Semba
  • Medicine
  • Clinical infectious diseases : an official…
  • 2002 (First Published: 1 September 2002)
  • Vitamin A is essential for immunity and growth. A controlled clinical that involved 697 human immunodeficiency virus (HIV)-infected pregnant women was conducted to determine whether vitamin AContinue Reading
  • David K Katzenstein, Scott M. Hammer, +9 authors Martin S. Hirsch
  • Medicine
  • The New England journal of medicine
  • 1996 (First Published: 10 October 1996)
  • BACKGROUND We studied measures of human immunodeficiency virus (HIV) replication, the viral phenotype, and immune function (CD4 cell counts) and the relation of changes in these indicators toContinue Reading
  • Don Brambilla, Cheryl Jennings, +11 authors Susan A. Fiscus
  • Biology, Medicine
  • Journal of clinical microbiology
  • 2003 (First Published: 1 May 2003)
  • Eleven laboratories evaluated the use of dried blood and plasma spots for quantitation of human immunodeficiency virus (HIV) RNA by two commercially available RNA assays, the Roche Amplicor HIV-1Continue Reading
  • Tamara S Flys, Dwight V. Nissley, +9 authors Susan H Eshleman
  • Medicine
  • The Journal of infectious diseases
  • 2005 (First Published: 1 July 2005)
  • BACKGROUND The HIV Network for Prevention Trials (HIVNET) 012 trial showed that NVP resistance (NVPR) emerged in some women and children after the administration of single-dose nevirapine (SD-NVP).Continue Reading
  • Craig W Hendrix, Ann C Collier, +12 authors Gary Calandra
  • Medicine
  • Journal of acquired immune deficiency syndromes
  • 2004 (First Published: 1 October 2004)
  • AMD3100 is a CXCR4 receptor inhibitor with anti-HIV-1 activity in vitro. We tested the safety, pharmacokinetics, and antiviral effect of AMD3100 administered for 10 days by continuous intravenousContinue Reading